SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001731122-24-000760
Filing Date
2024-05-09
Accepted
2024-05-09 16:35:55
Documents
48
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q e5644_10q.htm   iXBRL 10-Q 684679
2 EXHIBIT 31.1 e5644_ex31-1.htm EX-31.1 7969
3 EXHIBIT 31.2 e5644_ex31-2.htm EX-31.2 7932
4 EXHIBIT 32.1 e5644_ex32-1.htm EX-32.1 5772
5 GRAPHIC image_001.jpg GRAPHIC 27704
6 GRAPHIC image_002.jpg GRAPHIC 28815
  Complete submission text file 0001731122-24-000760.txt   3485019

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE avxl-20240331.xsd EX-101.SCH 26713
8 XBRL CALCULATION FILE avxl-20240331_cal.xml EX-101.CAL 27975
9 XBRL DEFINITION FILE avxl-20240331_def.xml EX-101.DEF 89589
10 XBRL LABEL FILE avxl-20240331_lab.xml EX-101.LAB 247467
11 XBRL PRESENTATION FILE avxl-20240331_pre.xml EX-101.PRE 193967
51 EXTRACTED XBRL INSTANCE DOCUMENT e5644_10q_htm.xml XML 443504
Mailing Address 630 5TH AVENUE 20TH FLOOR NEW YORK NY 10111
Business Address 630 5TH AVENUE 20TH FLOOR NEW YORK NY 10111 844-689-3939
ANAVEX LIFE SCIENCES CORP. (Filer) CIK: 0001314052 (see all company filings)

IRS No.: 980608404 | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-37606 | Film No.: 24931371
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)